BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26254304)

  • 1. Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis.
    Kumar A; Aguirre JD; Condos TE; Martinez-Torres RJ; Chaugule VK; Toth R; Sundaramoorthy R; Mercier P; Knebel A; Spratt DE; Barber KR; Shaw GS; Walden H
    EMBO J; 2015 Oct; 34(20):2506-21. PubMed ID: 26254304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
    Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
    Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Ubl/ubiquitin switch in the activation of Parkin.
    Sauvé V; Lilov A; Seirafi M; Vranas M; Rasool S; Kozlov G; Sprules T; Wang J; Trempe JF; Gehring K
    EMBO J; 2015 Oct; 34(20):2492-505. PubMed ID: 26254305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of phospho-ubiquitin-induced PARKIN activation.
    Wauer T; Simicek M; Schubert A; Komander D
    Nature; 2015 Aug; 524(7565):370-4. PubMed ID: 26161729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation.
    Condos TE; Dunkerley KM; Freeman EA; Barber KR; Aguirre JD; Chaugule VK; Xiao Y; Konermann L; Walden H; Shaw GS
    EMBO J; 2018 Dec; 37(23):. PubMed ID: 30446597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Function of Phosphoubiquitin in E3 Activation of Parkin.
    Walinda E; Morimoto D; Sugase K; Shirakawa M
    J Biol Chem; 2016 Aug; 291(32):16879-91. PubMed ID: 27284007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the second phosphoubiquitin-binding site in parkin.
    Fakih R; Sauvé V; Gehring K
    J Biol Chem; 2022 Jul; 298(7):102114. PubMed ID: 35690145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.
    Aguirre JD; Dunkerley KM; Mercier P; Shaw GS
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):298-303. PubMed ID: 28007983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of parkin activation by PINK1.
    Gladkova C; Maslen SL; Skehel JM; Komander D
    Nature; 2018 Jul; 559(7714):410-414. PubMed ID: 29995846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
    PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of human E3 ubiquitin ligase Parkin.
    Qiu S; Zhu S; Xu S; Han Y; Liu W; Zuo J
    Mol Med Rep; 2017 Oct; 16(4):4561-4568. PubMed ID: 28765939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.
    Kazlauskaite A; Martínez-Torres RJ; Wilkie S; Kumar A; Peltier J; Gonzalez A; Johnson C; Zhang J; Hope AG; Peggie M; Trost M; van Aalten DM; Alessi DR; Prescott AR; Knebel A; Walden H; Muqit MM
    EMBO Rep; 2015 Aug; 16(8):939-54. PubMed ID: 26116755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.
    Safadi SS; Barber KR; Shaw GS
    Biochemistry; 2011 Apr; 50(13):2603-10. PubMed ID: 21348451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of parkin activation by phosphorylation.
    Sauvé V; Sung G; Soya N; Kozlov G; Blaimschein N; Miotto LS; Trempe JF; Lukacs GL; Gehring K
    Nat Struct Mol Biol; 2018 Jul; 25(7):623-630. PubMed ID: 29967542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity.
    Ham SJ; Lee SY; Song S; Chung JR; Choi S; Chung J
    J Biol Chem; 2016 Jan; 291(4):1803-1816. PubMed ID: 26631732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin phosphorylated at Ser57 hyper-activates parkin.
    George S; Wang SM; Bi Y; Treidlinger M; Barber KR; Shaw GS; O'Donoghue P
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):3038-3046. PubMed ID: 28689991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.